Global Recombinant Follicle Stimulating Hormone Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 93

Published Date: 15 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Recombinant Follicle Stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Follicle Stimulating Hormone market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Infertility Treatment accounting for % of the Recombinant Follicle Stimulating Hormone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 75IU segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Recombinant Follicle Stimulating Hormone include Merck Serono, MSD, Techwell, GenSci, and Gedeon Richter, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Recombinant Follicle Stimulating Hormone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    75IU
    150IU
    Others

Market segment by Application can be divided into
    Infertility Treatment
    Assisted Reproductive Technology

The key market players for global Recombinant Follicle Stimulating Hormone market are listed below:
    Merck Serono
    MSD
    Techwell
    GenSci
    Gedeon Richter
    Teva

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Follicle Stimulating Hormone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Follicle Stimulating Hormone, with price, sales, revenue and global market share of Recombinant Follicle Stimulating Hormone from 2019 to 2022.
Chapter 3, the Recombinant Follicle Stimulating Hormone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Follicle Stimulating Hormone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Follicle Stimulating Hormone.
Chapter 13, 14, and 15, to describe Recombinant Follicle Stimulating Hormone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Recombinant Follicle Stimulating Hormone Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Recombinant Follicle Stimulating Hormone Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 75IU
        1.2.3 150IU
        1.2.4 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Recombinant Follicle Stimulating Hormone Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Infertility Treatment
        1.3.3 Assisted Reproductive Technology
    1.4 Global Recombinant Follicle Stimulating Hormone Market Size & Forecast
        1.4.1 Global Recombinant Follicle Stimulating Hormone Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Recombinant Follicle Stimulating Hormone Sales in Volume (2017-2028)
        1.4.3 Global Recombinant Follicle Stimulating Hormone Price (2017-2028)
    1.5 Global Recombinant Follicle Stimulating Hormone Production Capacity Analysis
        1.5.1 Global Recombinant Follicle Stimulating Hormone Total Production Capacity (2017-2028)
        1.5.2 Global Recombinant Follicle Stimulating Hormone Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Recombinant Follicle Stimulating Hormone Market Drivers
        1.6.2 Recombinant Follicle Stimulating Hormone Market Restraints
        1.6.3 Recombinant Follicle Stimulating Hormone Trends Analysis

2 Manufacturers Profiles
    2.1 Merck Serono
        2.1.1 Merck Serono Details
        2.1.2 Merck Serono Major Business
        2.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
        2.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 MSD
        2.2.1 MSD Details
        2.2.2 MSD Major Business
        2.2.3 MSD Recombinant Follicle Stimulating Hormone Product and Services
        2.2.4 MSD Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Techwell
        2.3.1 Techwell Details
        2.3.2 Techwell Major Business
        2.3.3 Techwell Recombinant Follicle Stimulating Hormone Product and Services
        2.3.4 Techwell Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 GenSci
        2.4.1 GenSci Details
        2.4.2 GenSci Major Business
        2.4.3 GenSci Recombinant Follicle Stimulating Hormone Product and Services
        2.4.4 GenSci Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Gedeon Richter
        2.5.1 Gedeon Richter Details
        2.5.2 Gedeon Richter Major Business
        2.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
        2.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Recombinant Follicle Stimulating Hormone Product and Services
        2.6.4 Teva Recombinant Follicle Stimulating Hormone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Recombinant Follicle Stimulating Hormone Breakdown Data by Manufacturer
    3.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Recombinant Follicle Stimulating Hormone
    3.4 Market Concentration Rate
        3.4.1 Top 3 Recombinant Follicle Stimulating Hormone Manufacturer Market Share in 2021
        3.4.2 Top 6 Recombinant Follicle Stimulating Hormone Manufacturer Market Share in 2021
    3.5 Global Recombinant Follicle Stimulating Hormone Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Recombinant Follicle Stimulating Hormone Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Recombinant Follicle Stimulating Hormone Market Size by Region
        4.1.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2017-2028)
        4.1.2 Global Recombinant Follicle Stimulating Hormone Revenue by Region (2017-2028)
    4.2 North America Recombinant Follicle Stimulating Hormone Revenue (2017-2028)
    4.3 Europe Recombinant Follicle Stimulating Hormone Revenue (2017-2028)
    4.4 Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue (2017-2028)
    4.5 South America Recombinant Follicle Stimulating Hormone Revenue (2017-2028)
    4.6 Middle East and Africa Recombinant Follicle Stimulating Hormone Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Type (2017-2028)
    5.2 Global Recombinant Follicle Stimulating Hormone Revenue by Type (2017-2028)
    5.3 Global Recombinant Follicle Stimulating Hormone Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Application (2017-2028)
    6.2 Global Recombinant Follicle Stimulating Hormone Revenue by Application (2017-2028)
    6.3 Global Recombinant Follicle Stimulating Hormone Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Recombinant Follicle Stimulating Hormone Sales by Type (2017-2028)
    7.2 North America Recombinant Follicle Stimulating Hormone Sales by Application (2017-2028)
    7.3 North America Recombinant Follicle Stimulating Hormone Market Size by Country
        7.3.1 North America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        7.3.2 North America Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Recombinant Follicle Stimulating Hormone Sales by Type (2017-2028)
    8.2 Europe Recombinant Follicle Stimulating Hormone Sales by Application (2017-2028)
    8.3 Europe Recombinant Follicle Stimulating Hormone Market Size by Country
        8.3.1 Europe Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        8.3.2 Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2017-2028)
    9.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2017-2028)
    9.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Region
        9.3.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Recombinant Follicle Stimulating Hormone Sales by Type (2017-2028)
    10.2 South America Recombinant Follicle Stimulating Hormone Sales by Application (2017-2028)
    10.3 South America Recombinant Follicle Stimulating Hormone Market Size by Country
        10.3.1 South America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        10.3.2 South America Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type (2017-2028)
    11.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application (2017-2028)
    11.3 Middle East & Africa Recombinant Follicle Stimulating Hormone Market Size by Country
        11.3.1 Middle East & Africa Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Recombinant Follicle Stimulating Hormone and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Recombinant Follicle Stimulating Hormone
    12.3 Recombinant Follicle Stimulating Hormone Production Process
    12.4 Recombinant Follicle Stimulating Hormone Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Recombinant Follicle Stimulating Hormone Typical Distributors
    13.3 Recombinant Follicle Stimulating Hormone Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Follicle Stimulating Hormone Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Recombinant Follicle Stimulating Hormone Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Merck Serono Basic Information, Manufacturing Base and Competitors
    Table 4. Merck Serono Major Business
    Table 5. Merck Serono Recombinant Follicle Stimulating Hormone Product and Services
    Table 6. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. MSD Basic Information, Manufacturing Base and Competitors
    Table 8. MSD Major Business
    Table 9. MSD Recombinant Follicle Stimulating Hormone Product and Services
    Table 10. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Techwell Basic Information, Manufacturing Base and Competitors
    Table 12. Techwell Major Business
    Table 13. Techwell Recombinant Follicle Stimulating Hormone Product and Services
    Table 14. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. GenSci Basic Information, Manufacturing Base and Competitors
    Table 16. GenSci Major Business
    Table 17. GenSci Recombinant Follicle Stimulating Hormone Product and Services
    Table 18. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Gedeon Richter Basic Information, Manufacturing Base and Competitors
    Table 20. Gedeon Richter Major Business
    Table 21. Gedeon Richter Recombinant Follicle Stimulating Hormone Product and Services
    Table 22. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Teva Basic Information, Manufacturing Base and Competitors
    Table 24. Teva Major Business
    Table 25. Teva Recombinant Follicle Stimulating Hormone Product and Services
    Table 26. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Global Recombinant Follicle Stimulating Hormone Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
    Table 28. Global Recombinant Follicle Stimulating Hormone Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 29. Market Position of Manufacturers in Recombinant Follicle Stimulating Hormone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 30. Global Recombinant Follicle Stimulating Hormone Production Capacity by Company, (K Doses): 2020 VS 2021
    Table 31. Head Office and Recombinant Follicle Stimulating Hormone Production Site of Key Manufacturer
    Table 32. Recombinant Follicle Stimulating Hormone New Entrant and Capacity Expansion Plans
    Table 33. Recombinant Follicle Stimulating Hormone Mergers & Acquisitions in the Past Five Years
    Table 34. Global Recombinant Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 35. Global Recombinant Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 36. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 37. Global Recombinant Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 38. Global Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 39. Global Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 40. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2017-2022) & (USD Million)
    Table 41. Global Recombinant Follicle Stimulating Hormone Revenue by Type (2023-2028) & (USD Million)
    Table 42. Global Recombinant Follicle Stimulating Hormone Price by Type (2017-2022) & (USD/Dose)
    Table 43. Global Recombinant Follicle Stimulating Hormone Price by Type (2023-2028) & (USD/Dose)
    Table 44. Global Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 45. Global Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 46. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2017-2022) & (USD Million)
    Table 47. Global Recombinant Follicle Stimulating Hormone Revenue by Application (2023-2028) & (USD Million)
    Table 48. Global Recombinant Follicle Stimulating Hormone Price by Application (2017-2022) & (USD/Dose)
    Table 49. Global Recombinant Follicle Stimulating Hormone Price by Application (2023-2028) & (USD/Dose)
    Table 50. North America Recombinant Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 51. North America Recombinant Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 52. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 53. North America Recombinant Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 54. North America Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 55. North America Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 56. North America Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 57. North America Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 58. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 59. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 60. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 61. Europe Recombinant Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 62. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 63. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 64. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 65. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 66. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 67. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 68. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 69. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 70. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 71. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 72. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 73. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 74. South America Recombinant Follicle Stimulating Hormone Sales by Country (2017-2022) & (K Doses)
    Table 75. South America Recombinant Follicle Stimulating Hormone Sales by Country (2023-2028) & (K Doses)
    Table 76. South America Recombinant Follicle Stimulating Hormone Revenue by Country (2017-2022) & (USD Million)
    Table 77. South America Recombinant Follicle Stimulating Hormone Revenue by Country (2023-2028) & (USD Million)
    Table 78. South America Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 79. South America Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 80. South America Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 81. South America Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 82. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Region (2017-2022) & (K Doses)
    Table 83. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Region (2023-2028) & (K Doses)
    Table 84. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Region (2017-2022) & (USD Million)
    Table 85. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue by Region (2023-2028) & (USD Million)
    Table 86. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type (2017-2022) & (K Doses)
    Table 87. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Type (2023-2028) & (K Doses)
    Table 88. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application (2017-2022) & (K Doses)
    Table 89. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales by Application (2023-2028) & (K Doses)
    Table 90. Recombinant Follicle Stimulating Hormone Raw Material
    Table 91. Key Manufacturers of Recombinant Follicle Stimulating Hormone Raw Materials
    Table 92. Direct Channel Pros & Cons
    Table 93. Indirect Channel Pros & Cons
    Table 94. Recombinant Follicle Stimulating Hormone Typical Distributors
    Table 95. Recombinant Follicle Stimulating Hormone Typical Customers
List of Figures
    Figure 1. Recombinant Follicle Stimulating Hormone Picture
    Figure 2. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type in 2021
    Figure 3. 75IU
    Figure 4. 150IU
    Figure 5. Others
    Figure 6. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application in 2021
    Figure 7. Infertility Treatment
    Figure 8. Assisted Reproductive Technology
    Figure 9. Global Recombinant Follicle Stimulating Hormone Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
    Figure 10. Global Recombinant Follicle Stimulating Hormone Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Recombinant Follicle Stimulating Hormone Sales (2017-2028) & (K Doses)
    Figure 12. Global Recombinant Follicle Stimulating Hormone Price (2017-2028) & (USD/Dose)
    Figure 13. Global Recombinant Follicle Stimulating Hormone Production Capacity (2017-2028) & (K Doses)
    Figure 14. Global Recombinant Follicle Stimulating Hormone Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Recombinant Follicle Stimulating Hormone Market Drivers
    Figure 16. Recombinant Follicle Stimulating Hormone Market Restraints
    Figure 17. Recombinant Follicle Stimulating Hormone Market Trends
    Figure 18. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Manufacturer in 2021
    Figure 19. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Manufacturer in 2021
    Figure 20. Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Recombinant Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Recombinant Follicle Stimulating Hormone Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 24. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 25. North America Recombinant Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Recombinant Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 28. South America Recombinant Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue (2017-2028) & (USD Million)
    Figure 30. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 31. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Type (2017-2028)
    Figure 32. Global Recombinant Follicle Stimulating Hormone Price by Type (2017-2028) & (USD/Dose)
    Figure 33. Global Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 34. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Application (2017-2028)
    Figure 35. Global Recombinant Follicle Stimulating Hormone Price by Application (2017-2028) & (USD/Dose)
    Figure 36. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 37. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 38. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 39. North America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 40. United States Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 44. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 45. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 46. Europe Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 56. China Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 63. South America Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 64. South America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2017-2028)
    Figure 65. South America Recombinant Follicle Stimulating Hormone Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Recombinant Follicle Stimulating Hormone Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Recombinant Follicle Stimulating Hormone Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Recombinant Follicle Stimulating Hormone in 2021
    Figure 77. Manufacturing Process Analysis of Recombinant Follicle Stimulating Hormone
    Figure 78. Recombinant Follicle Stimulating Hormone Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck Serono
MSD
Techwell
GenSci
Gedeon Richter
Teva

Related Reports

Global Recombinant Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Recombinant Follicle Stimulating Hormone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 30 Jan 2021

date Pharma & Healthcare

The Recombinant Follicle Stimulating Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Recombinant Follicle Stimulating Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Recombinant Follicle Stimulating Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

Recombinant FSH is produced through recombinant DNA technology. These products are pure and do not contain the "contaminants" seen in urine extraction FSH. It is given subcutaneously with much less discomfort. Both human and genetically derived products are difficult to obtain and manufacture and are therefore expensive.

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2023-2029

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2023-2029

date 03 Mar 2023

date Pharma & Healthcare

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Recombinant Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Follicle Stimulating Hormone Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Follicle Stimulating Hormone market size was valued at USD 1075.9 million in 2023 and is forecast to a readjusted size of USD 1550.5 million by 2030 with a CAGR of 5.4% during review period.

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

Global Recombinant Follicle Stimulating Hormone Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Recombinant Follicle Stimulating Hormone market size is expected to reach $ 1550.5 million by 2030, rising at a market growth of 5.4% CAGR during the forecast period (2024-2030).

Product Tags

recombinant follicle stimulating hormone

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>